Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Nyce

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Trends in Pharmacological Sciences|April 2, 1999
Insight into adenosine receptor function using antisense and gene-knockout approachesJ W Nyce
Expert Opinion on Investigational Drugs|July 5, 2005
Respirable antisense oligonucleotides as novel therapeutic agents for asthma and other pulmonary diseasesJ W Nyce
Carcinogenesis|November 1, 1994
Inhibition of protein farnesyltransferase: a possible mechanism of tumor prevention by dehydroepiandrosterone sulfateS Schulz, J W Nyce
Cancer Research|December 15, 1991
Inhibition of protein isoprenylation and p21ras membrane association by dehydroepiandrosterone in human colonic adenocarcinoma cells in vitroS Schulz, J W Nyce
Respiratory Research|November 1, 2001
Respirable antisense oligonucleotides: a new drug class for respiratory diseaseM Tanaka, J W Nyce
The Journal of Allergy and Clinical Immunology|August 19, 1999
Oligonucleotide therapy of allergic asthmaW J Metzger, J W Nyce
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Respirable antisense oligonucleotide (RASON) therapy for allergic asthmaW J Metzger, J W Nyce
Cancer Letters|January 1, 1997
Induction of peroxisomal enzymes in rat liver by dehydroepiandrosterone sulfateS A Khan, J W Nyce
Nature|February 20, 1997
DNA antisense therapy for asthma in an animal modelJ W Nyce, W J Metzger
Pharmacology & Toxicology|March 1, 1997
Effects of ubiquinone and mevalonic acid on hepatic peroxisomal enzymes induced by dehydroepiandrosteroneS A Khan, J W Nyce
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Trends in Pharmacological Sciences|April 2, 1999
Insight into adenosine receptor function using antisense and gene-knockout approachesJ W Nyce
Expert Opinion on Investigational Drugs|July 5, 2005
Respirable antisense oligonucleotides as novel therapeutic agents for asthma and other pulmonary diseasesJ W Nyce
Carcinogenesis|November 1, 1994
Inhibition of protein farnesyltransferase: a possible mechanism of tumor prevention by dehydroepiandrosterone sulfateS Schulz, J W Nyce
Cancer Research|December 15, 1991
Inhibition of protein isoprenylation and p21ras membrane association by dehydroepiandrosterone in human colonic adenocarcinoma cells in vitroS Schulz, J W Nyce
Respiratory Research|November 1, 2001
Respirable antisense oligonucleotides: a new drug class for respiratory diseaseM Tanaka, J W Nyce
The Journal of Allergy and Clinical Immunology|August 19, 1999
Oligonucleotide therapy of allergic asthmaW J Metzger, J W Nyce
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Respirable antisense oligonucleotide (RASON) therapy for allergic asthmaW J Metzger, J W Nyce
Cancer Letters|January 1, 1997
Induction of peroxisomal enzymes in rat liver by dehydroepiandrosterone sulfateS A Khan, J W Nyce
Nature|February 20, 1997
DNA antisense therapy for asthma in an animal modelJ W Nyce, W J Metzger
Pharmacology & Toxicology|March 1, 1997
Effects of ubiquinone and mevalonic acid on hepatic peroxisomal enzymes induced by dehydroepiandrosteroneS A Khan, J W Nyce
Pageof 3